Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04451850 · ClinicalTrials.gov registry record
HRV as a Marker of Treatment Response in PAH Arterial Hypertension
A clinical trial, sponsored by University of Cincinnati.
- Completed
- Registry status
- 24
- Enrollment target
NCT04451850 is a clinical trial that has completed, run by University of Cincinnati. The registered enrollment target is 24 participants.
The verdict
NCT04451850 has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
This is a prospective longitudinal cohort study to determine the value of HRV obtained using noninvasive actigraphy to quantify the response to pulmonary vasodilator therapy in newly diagnosed PAH patients
Interventions
- OTHER Noninvasive actigraphy monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2024-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04451850
The ClinicalTrials.gov registry entry for NCT04451850 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Noninvasive actigraphy monitor is the first listed.
NCT04451850 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04451850 about?
NCT04451850 is a clinical study titled "HRV as a Marker of Treatment Response in PAH Arterial Hypertension". This is a prospective longitudinal cohort study to determine the value of HRV obtained using noninvasive actigraphy to quantify the response to pulmonary vasodilator therapy in newly diagnosed PAH patients
What is the current status of trial NCT04451850?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2021-06-01. Estimated completion is 2024-12-01.
What interventions are being tested in trial NCT04451850?
The interventions under investigation include: Noninvasive actigraphy monitor (OTHER).
Who is sponsoring clinical trial NCT04451850?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.